The Burden of Cost in Bronchiolitis Obliterans Syndrome: Predictions for the Next Decade
In health economics, costs can be divided into both direct and indirect categories. Direct costs tend to consist of medical costs, which are those directly attributed to health care interventions (e.g., hospitalizations, pharmaceuticals, devices), and non-medical direct costs such as monitoring and...
Saved in:
Main Authors: | Christopher A. Jones, David G. Chapman, Peter Weimersheimer, Luca Fernandez, Oscar Alejandro Mesa, Christian Peters, Bart M. Vanaudenaerde, Mitchell C. Norotsky, Robin Vos |
---|---|
Format: | Article |
Language: | English |
Published: |
Columbia Data Analytics, LLC
2016-06-01
|
Series: | Journal of Health Economics and Outcomes Research |
Online Access: | https://doi.org/10.36469/9815 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Estimating the Burden of Cost in Chronic Graft-versus-Host Disease: A Human Capital Approach
by: Chris A. Jones, et al.
Published: (2016-06-01) -
Call to Action: Lead Pharmacy into the Next Decade
by: Gregory Zumach, et al.
Published: (2025-01-01) -
Call to Action: Lead Pharmacy into the Next Decade
by: Kerry K Fierke, et al.
Published: (2025-01-01) -
Call to Action: Lead Pharmacy into the Next Decade
by: Kerry K Fierke, et al.
Published: (2025-01-01) -
Can Lp(a) become the next A1C? A case for digital health management tools to overcome inertia to Lipoprotein (a) testing
by: Christof Wedemeyer, et al.
Published: (2025-02-01)